These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19240707)

  • 1. Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease.
    Baumgart DC; Lowder JN; Targan SR; Sandborn WJ; Frankel MB
    Am J Gastroenterol; 2009 Apr; 104(4):868-76. PubMed ID: 19240707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
    Włodarczyk M; Sobolewska A; Wójcik B; Loga K; Fichna J; Wiśniewska-Jarosińska M
    World J Gastroenterol; 2014 Jun; 20(22):7019-26. PubMed ID: 24944497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
    Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
    Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of hepatic function in new cases of pulmonary tuberculosis due to the use of standard chemotherapy regimens I and IIB].
    Abdullaev RIu; Vaniev EV; Kaminskaia GO; Vasil'eva IA; Komissarova OG
    Probl Tuberk Bolezn Legk; 2009; (2):57-61. PubMed ID: 19382645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propafenone-induced liver injury.
    Spinler SA; Elder CA; Kindwall KE
    Ann Pharmacother; 1992; 26(7-8):926-8. PubMed ID: 1354511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, pattern, and etiology of elevated liver enzymes in pediatric inflammatory bowel disease.
    Pusateri AJ; Kim SC; Dotson JL; Balint JP; Potter CJ; Boyle BM; Crandall WV
    J Pediatr Gastroenterol Nutr; 2015 May; 60(5):592-7. PubMed ID: 25493346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis.
    Baumgart DC; Targan SR; Dignass AU; Mayer L; van Assche G; Hommes DW; Hanauer SB; Mahadevan U; Reinisch W; Plevy SE; Salzberg BA; Buchman AL; Mechkov GM; Krastev ZA; Lowder JN; Frankel MB; Sandborn WJ
    Inflamm Bowel Dis; 2010 Apr; 16(4):620-9. PubMed ID: 19714757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum hepatic biochemical activity in two populations of workers exposed to styrene.
    Brodkin CA; Moon JD; Camp J; Echeverria D; Redlich CA; Willson RA; Checkoway H
    Occup Environ Med; 2001 Feb; 58(2):95-102. PubMed ID: 11160987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors.
    Norman DJ; Vincenti F; de Mattos AM; Barry JM; Levitt DJ; Wedel NI; Maia M; Light SE
    Transplantation; 2000 Dec; 70(12):1707-12. PubMed ID: 11152101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive values of various liver function tests with respect to the diagnosis of liver disease.
    Sheehan M; Haythorn P
    Clin Biochem; 1979 Dec; 12(6):262-3. PubMed ID: 43785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study.
    Huang MJ; Li KL; Wei JS; Wu SS; Fan KD; Liaw YF
    Am J Gastroenterol; 1994 Jul; 89(7):1071-6. PubMed ID: 7912472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
    Plevy S; Salzberg B; Van Assche G; Regueiro M; Hommes D; Sandborn W; Hanauer S; Targan S; Mayer L; Mahadevan U; Frankel M; Lowder J
    Gastroenterology; 2007 Nov; 133(5):1414-22. PubMed ID: 17920064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function tests: what is the risk?
    Titcomb CP
    J Insur Med; 2003; 35(1):26-35. PubMed ID: 14694823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory assessment of hepatic injury in the woodchuck (Marmota monax).
    Hornbuckle WE; Graham ES; Roth L; Baldwin BH; Wickenden C; Tennant BC
    Lab Anim Sci; 1985 Aug; 35(4):376-81. PubMed ID: 2864472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum liver enzymes after laparoscopic cholecystectomy.
    Sakorafas G; Anagnostopoulos G; Stafyla V; Koletis T; Kotsifopoulos N; Tsiakos S; Kassaras G
    N Z Med J; 2005 Feb; 118(1210):U1317. PubMed ID: 15776093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of circulating cytokines in patients with Crohn's disease under maintenance therapy with infliximab.
    Ogawa K; Matsumoto T; Esaki M; Torisu T; Iida M
    J Crohns Colitis; 2012 Jun; 6(5):529-35. PubMed ID: 22398057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
    Romanò M; Colombo E; Spinelli A
    G Ital Cardiol; 1987 Feb; 17(2):149-50. PubMed ID: 2886392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.